ASCO Obesity & Cancer Summit and Will Changing Physician Incentives Lower the Cost of Quality Cancer Care?
This week in healthcare, the health care impacts of last week’s elections and a study examines the impact of physician incentives on the cost of cancer care.
Changing Physician Incentives for Affordable, Quality Cancer Care: Results of an Episode Payment Model
A study authored by Lee Newcomer, M.D. focuses on testing “the combination of an episode payment coupled with actionable use and quality data as an incentive to improve quality and reduce costs” found that “modifying the current fee-for-service payment system for cancer therapy with feedback data and financial incentives that reward outcomes and cost efficiency resulted in a significant total cost reduction.” It also found that “eliminating existing financial chemotherapy drug incentives paradoxically increased the use of chemotherapy.”
ASCO Holds Research Summit on Obesity and Cancer
This week ASCO held the “Research Summit on Advancing Obesity Clinical Trials in Cancer Survivors,” which was its “first-ever research summit to discuss challenges and opportunities in obesity and cancer research with representatives from many leading U.S. research institutions, cancer centers, and other organizations and federal agencies.”
On October 31st, CMS released the final rule for the 2015 Hospital Outpatient Prospective Payment System (OPPS) and Physician Fee Schedule (PFS). The rule estimates that OPPS payments will “increase by 2.3 percent for CY 2015.”
A new analysis released by the RAND Corporation suggests that the introduction of biosimilar alternatives to compete with existing biologic drugs “could cut spending on biologics in the United States by $44 billion over the next decade.”
Although the Department of Health and Human Services (HHS) has done much work to improve the workings of Healthcare.gov, some insurers are still concerned about glitches that “are preventing HHS from telling insurers that consumers have left for another company.”
As the smoke clears after the U.S. midterm elections, the election of several Republican governors makes Medicaid expansion unlikely in Florida, Georgia, Kansas, Maine, and Wisconsin. As one commentator put it, ““No one would say it was a good night for the prospects of Medicaid expansion.”
Want more health care landscape updates and insights? Follow us on Twitter @innovpartners.